Latest filing published 17 May 2018 for ZEVRA THERAPEUTICS, INC., €30k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 18 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -76.5%Entry US$101.60 · Close at T+365 US$23.84
- -32.6%Entry US$60.80 · Close at T+365 US$40.96
- +72.7%Entry US$44.00 · Close at T+365 US$76.00
- +43.7%Entry US$69.60 · Close at T+365 US$100.00
- +43.2%Entry US$76.00 · Close at T+365 US$108.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Daniel L. Cohen: trading record in brief
This profile gathers the share dealings of Daniel L. Cohen in Zevra Therapeutics, Inc. The record holds 23 filings, for trades running from 2 September 2016 to 15 May 2018.
The open-market record is one-sided, with 20 purchases worth €156k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2018: 4 purchases and no sales on the market.
The median purchase comes to €6,335. Clusters matter here: 7 out of 18 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 18 purchases old enough to measure, the stock rose over the following 90 days in 28% of cases; the median change was -19.7%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 17 May 2018, reports an open-market purchase of €30k in Zevra Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Daniel L. Cohen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,500 shares@ US$6.4520.4% of flowCommon StockSEC:0001437749-18-010288:0Canonical exit: 13 Aug 2018 (T+90)
- 2,000 shares@ US$6.457.4% of flowCommon StockSEC:0001437749-18-010288:1Canonical exit: 13 Aug 2018 (T+90)
- 200 shares@ US$6.450.7% of flowCommon StockSEC:0001437749-18-010288:2Canonical exit: 13 Aug 2018 (T+90)
- 1,250 shares0Common StockSEC:0001437749-17-019919:5
- 1,250 shares0Common StockSEC:0001437749-17-019919:6
- 2,500 shares0Common StockSEC:0001437749-17-019919:4
- 1,145 shares@ US$3.702.4% of flowCommon StockSEC:0001437749-17-019919:0Canonical exit: 25 Feb 2018 (T+90)
- 1,310 shares@ US$3.752.8% of flowCommon StockSEC:0001437749-17-019919:1Canonical exit: 25 Feb 2018 (T+90)
- 2,990 shares@ US$3.806.5% of flowCommon StockSEC:0001437749-17-019919:2Canonical exit: 25 Feb 2018 (T+90)
- 2,055 shares@ US$3.854.5% of flowCommon StockSEC:0001437749-17-019919:3Canonical exit: 25 Feb 2018 (T+90)
- 5,000 shares@ US$2.587.4% of flowCommon StockSEC:0001437749-17-015335:0Canonical exit: 22 Nov 2017 (T+90)
- 1,974 shares@ US$4.104.9% of flowCommon StockSEC:0001437749-17-010179:0Canonical exit: 23 Aug 2017 (T+90)
- 526 shares@ US$4.141.3% of flowCommon StockSEC:0001437749-17-010179:1Canonical exit: 23 Aug 2017 (T+90)
- 1,500 shares@ US$4.334.1% of flowCommon StockSEC:0001437749-17-005785:0Canonical exit: 27 Jun 2017 (T+90)
- 1,000 shares@ US$4.703.0% of flowCommon StockSEC:0001437749-17-005785:1Canonical exit: 29 Jun 2017 (T+90)
- 747 shares@ US$3.481.7% of flowCommon StockSEC:0001562180-16-003645:0Canonical exit: 28 Feb 2017 (T+90)
- 4,253 shares@ US$3.509.5% of flowCommon StockSEC:0001562180-16-003645:1Canonical exit: 28 Feb 2017 (T+90)
- 1,310 shares@ US$4.593.7% of flowCommon StockSEC:0001437749-16-038425:0Canonical exit: 1 Dec 2016 (T+90)
- 2,000 shares@ US$4.595.6% of flowCommon StockSEC:0001437749-16-038425:1Canonical exit: 1 Dec 2016 (T+90)
- 1,000 shares@ US$4.602.8% of flowCommon StockSEC:0001437749-16-038425:3Canonical exit: 1 Dec 2016 (T+90)
- 3,690 shares@ US$5.0111.2% of flowCommon StockSEC:0001437749-16-038425:4Canonical exit: 5 Dec 2016 (T+90)
21 of 21 declarations